The review article by scientists from the Laboratory of Pharmaceutical Pharmacology (Latvian Institute of Organic Synthesis) and Uppsala University (Sweden) on acylcarnitines has been published in the journal “” (IF = 18.9).
The review includes an overview of acylcarnitines – nomenclature, biomarkers, therapeutic potential, drug targets and clinical trials.
Read the review:
Dambrova, M.*; Makrecka-Kuka, M.; Kuka, J.; Vilskersts, R.; Nordberg, D.; Attwood, M. M.; Smesny, S.; Sen, Z. D.; Guo, A. C.; Oler, E.; Tian, S.; Zheng, J.; Wishart, D.S.; Liepinsh, E.; , H.B.*
Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials.
Pharmacol.Rev. 2022, 74(3), 506-551. DOI: 10.1124/pharmrev.121.000408